Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

John Arcaroli

Concepts (368)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
19
2018
791
2.540
Why?
Xenograft Model Antitumor Assays
21
2024
868
1.480
Why?
Antineoplastic Agents
17
2018
2122
1.360
Why?
Drug Resistance, Neoplasm
7
2016
800
1.040
Why?
Benzodioxoles
3
2012
115
1.010
Why?
Quinazolines
4
2012
250
1.010
Why?
Camptothecin
4
2016
115
0.900
Why?
Receptor, Notch1
3
2015
64
0.860
Why?
Aldehyde Dehydrogenase
6
2017
100
0.860
Why?
Mice, Nude
16
2024
696
0.800
Why?
Haplotypes
4
2012
494
0.750
Why?
Phosphatidylinositol 3-Kinases
10
2018
366
0.710
Why?
Gene Dosage
3
2015
140
0.640
Why?
Wnt Signaling Pathway
5
2024
192
0.630
Why?
Neutrophils
13
2007
1236
0.620
Why?
src-Family Kinases
3
2017
92
0.600
Why?
Pancreatic Neoplasms
6
2024
935
0.590
Why?
Amyloid Precursor Protein Secretases
3
2014
80
0.590
Why?
Endotoxemia
9
2004
86
0.580
Why?
Anilides
2
2018
73
0.580
Why?
Enzyme Inhibitors
5
2016
839
0.570
Why?
Protein Kinase Inhibitors
9
2018
916
0.570
Why?
Biomarkers, Tumor
9
2018
1272
0.540
Why?
Mice
41
2024
17733
0.530
Why?
Acute Lung Injury
2
2011
287
0.520
Why?
Pyridines
4
2018
506
0.510
Why?
Receptors, Notch
2
2015
88
0.500
Why?
Tankyrases
1
2016
15
0.500
Why?
Cell Line, Tumor
21
2024
3405
0.490
Why?
Drug Discovery
1
2016
141
0.480
Why?
Polymorphism, Genetic
3
2007
659
0.460
Why?
NF-kappa B
13
2007
691
0.460
Why?
3' Untranslated Regions
2
2012
145
0.450
Why?
DNA Copy Number Variations
1
2015
182
0.440
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2014
86
0.440
Why?
Proto-Oncogene Proteins c-met
1
2014
75
0.430
Why?
Tetrahydronaphthalenes
1
2013
29
0.410
Why?
Valine
1
2013
82
0.410
Why?
Animals
44
2024
36823
0.390
Why?
Mitogen-Activated Protein Kinases
7
2014
313
0.380
Why?
Sepsis
3
2007
614
0.360
Why?
Lipopolysaccharides
9
2007
886
0.350
Why?
Signal Transduction
17
2018
5075
0.350
Why?
Proto-Oncogene Proteins
8
2018
647
0.340
Why?
Superoxide Dismutase
3
2008
346
0.330
Why?
Urokinase-Type Plasminogen Activator
2
2007
29
0.330
Why?
Cell Proliferation
13
2024
2472
0.320
Why?
Interleukins
1
2011
250
0.310
Why?
Neoplasm Metastasis
4
2016
657
0.310
Why?
Hemorrhage
6
2004
721
0.310
Why?
Class I Phosphatidylinositol 3-Kinases
3
2014
95
0.300
Why?
Heterografts
3
2018
138
0.290
Why?
HCT116 Cells
4
2018
80
0.280
Why?
Apoptosis
11
2018
2551
0.270
Why?
SOXB1 Transcription Factors
2
2018
61
0.270
Why?
Carcinoma, Pancreatic Ductal
2
2024
287
0.270
Why?
Azepines
2
2018
90
0.260
Why?
Benzimidazoles
3
2013
170
0.260
Why?
Promoter Regions, Genetic
1
2011
1249
0.260
Why?
Mutation
3
2012
3946
0.250
Why?
Immunoblotting
5
2015
306
0.250
Why?
Neutrophil Activation
5
2003
80
0.230
Why?
Receptors, Interleukin-1
1
2006
216
0.230
Why?
beta Catenin
3
2016
253
0.230
Why?
Humans
46
2024
136764
0.230
Why?
TOR Serine-Threonine Kinases
4
2018
412
0.220
Why?
Oligonucleotide Array Sequence Analysis
6
2015
766
0.220
Why?
Pyrimidines
2
2018
470
0.210
Why?
Intracellular Signaling Peptides and Proteins
2
2006
455
0.210
Why?
Adrenergic alpha-Antagonists
2
2002
34
0.210
Why?
Mice, Inbred BALB C
10
2003
1269
0.210
Why?
Proto-Oncogene Proteins c-akt
8
2018
437
0.210
Why?
Colonic Neoplasms
2
2016
254
0.200
Why?
Adrenergic alpha-Agonists
1
2002
28
0.200
Why?
Proto-Oncogene Proteins c-raf
1
2002
45
0.200
Why?
Female
24
2018
72787
0.190
Why?
Genetic Predisposition to Disease
1
2011
2412
0.190
Why?
Neuroimmunomodulation
1
2002
65
0.190
Why?
Aged
11
2016
23794
0.190
Why?
ras Proteins
3
2013
153
0.190
Why?
Adrenergic beta-Agonists
1
2002
133
0.180
Why?
Middle Aged
12
2016
33228
0.180
Why?
Adrenergic beta-Antagonists
2
2002
323
0.180
Why?
Hemoptysis
1
2000
36
0.170
Why?
Polymorphism, Single Nucleotide
4
2011
2184
0.170
Why?
In Situ Hybridization, Fluorescence
2
2012
317
0.160
Why?
Adult
11
2016
37630
0.160
Why?
Cytokines
4
2005
2083
0.160
Why?
Carcinoma, Squamous Cell
2
2016
683
0.160
Why?
Head and Neck Neoplasms
2
2016
604
0.150
Why?
Male
24
2016
67309
0.150
Why?
Cell Transformation, Neoplastic
2
2018
327
0.150
Why?
DNA Topoisomerases, Type II
2
2016
45
0.150
Why?
Transplantation, Heterologous
2
2016
194
0.150
Why?
CDC2 Protein Kinase
1
2018
31
0.150
Why?
MAP Kinase Kinase Kinases
2
2015
73
0.140
Why?
Oncogene Proteins v-abl
1
2017
5
0.140
Why?
Cyclic AMP Response Element-Binding Protein
4
2003
145
0.140
Why?
Mitogen-Activated Protein Kinase Kinases
3
2010
134
0.140
Why?
p38 Mitogen-Activated Protein Kinases
6
2007
283
0.140
Why?
Dasatinib
1
2017
54
0.140
Why?
Proto-Oncogene Proteins p21(ras)
5
2016
267
0.140
Why?
Immunohistochemistry
5
2017
1733
0.140
Why?
Case-Control Studies
3
2011
3540
0.140
Why?
Gene Expression Profiling
4
2018
1772
0.130
Why?
Angiogenesis Inhibitors
2
2018
226
0.130
Why?
Neovascularization, Pathologic
2
2018
301
0.130
Why?
Intercellular Signaling Peptides and Proteins
2
2015
382
0.130
Why?
Receptors, Cell Surface
2
2012
382
0.130
Why?
Phosphatidylinositol 3-Kinase
1
2016
26
0.130
Why?
Adenocarcinoma
2
2014
938
0.130
Why?
Axin Protein
1
2016
19
0.130
Why?
Aurora Kinase A
1
2016
56
0.130
Why?
Corynebacterium
1
2017
49
0.130
Why?
Corynebacterium Infections
1
2017
41
0.130
Why?
Antigens, Neoplasm
2
2016
319
0.130
Why?
Transcription Factor 7-Like 2 Protein
1
2016
23
0.130
Why?
Neoplasms, Experimental
1
2017
176
0.120
Why?
Cell Cycle
5
2018
601
0.120
Why?
Neoplastic Stem Cells
2
2018
399
0.120
Why?
Autophagy
1
2018
280
0.120
Why?
Serrate-Jagged Proteins
1
2015
27
0.120
Why?
Jagged-1 Protein
1
2015
23
0.120
Why?
Neoplasms
3
2016
2644
0.120
Why?
Genotype
3
2012
1914
0.120
Why?
Aged, 80 and over
5
2014
7585
0.120
Why?
RNA, Small Interfering
2
2015
622
0.120
Why?
RNA, Messenger
5
2016
2831
0.120
Why?
Drug Synergism
2
2014
382
0.120
Why?
Gene Duplication
1
2015
68
0.120
Why?
Retinaldehyde
1
2015
4
0.120
Why?
HMGB1 Protein
2
2007
50
0.120
Why?
Pyrazoles
1
2018
423
0.120
Why?
Acetaldehyde
1
2015
17
0.120
Why?
Chemokines
5
2003
228
0.110
Why?
Pyrimidinones
1
2015
113
0.110
Why?
Acridines
1
2014
7
0.110
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2014
1682
0.110
Why?
Neoplasm Transplantation
4
2016
257
0.110
Why?
Chemokine CXCL2
4
2001
43
0.110
Why?
Topoisomerase II Inhibitors
1
2014
25
0.110
Why?
Respiration, Artificial
2
2011
642
0.110
Why?
Benzazepines
1
2014
39
0.110
Why?
Wnt Proteins
1
2015
133
0.110
Why?
Pyridones
1
2015
168
0.110
Why?
Calcium-Binding Proteins
1
2015
218
0.110
Why?
Cell Cycle Proteins
1
2018
613
0.110
Why?
Gene Expression Regulation
2
2007
2605
0.110
Why?
Cell Growth Processes
1
2013
52
0.100
Why?
Cellular Senescence
1
2015
186
0.100
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2012
8
0.100
Why?
Random Allocation
1
2013
353
0.100
Why?
Tumor Suppressor Proteins
1
2015
327
0.100
Why?
Disease Models, Animal
4
2018
4281
0.100
Why?
Enzyme Activation
6
2003
810
0.100
Why?
DNA-Binding Proteins
3
2016
1501
0.100
Why?
Aldehyde Dehydrogenase, Mitochondrial
3
2017
23
0.100
Why?
Molecular Targeted Therapy
1
2015
411
0.100
Why?
Gene Knockdown Techniques
1
2013
327
0.100
Why?
Chemokine CXCL12
1
2012
81
0.100
Why?
Receptors, CXCR4
1
2012
86
0.090
Why?
Cyclosporine
1
2013
268
0.090
Why?
Linkage Disequilibrium
2
2012
268
0.090
Why?
Immunoprecipitation
1
2012
155
0.090
Why?
Lung Diseases
3
2004
767
0.090
Why?
Hydroxamic Acids
1
2011
89
0.090
Why?
Lung
8
2004
4052
0.090
Why?
Melanoma
1
2018
757
0.090
Why?
Prognosis
3
2015
4013
0.090
Why?
Peroxidase
2
2002
175
0.090
Why?
Genetic Markers
1
2012
344
0.090
Why?
Drug Design
1
2012
167
0.090
Why?
PTEN Phosphohydrolase
1
2012
162
0.090
Why?
Sirolimus
1
2012
275
0.090
Why?
Antibodies, Monoclonal, Humanized
2
2013
801
0.080
Why?
Genetic Association Studies
1
2012
375
0.080
Why?
Histone Deacetylase Inhibitors
1
2011
210
0.080
Why?
Administration, Oral
1
2012
813
0.080
Why?
Phosphorylation
3
2018
1758
0.080
Why?
Cetuximab
3
2016
95
0.080
Why?
Tumor Necrosis Factor-alpha
4
2004
1242
0.080
Why?
Cell Separation
1
2010
317
0.080
Why?
Membrane Proteins
1
2015
1163
0.070
Why?
G2 Phase Cell Cycle Checkpoints
2
2018
44
0.070
Why?
Gene Expression Regulation, Neoplastic
4
2016
1396
0.070
Why?
Antibodies, Monoclonal
1
2015
1430
0.070
Why?
Models, Statistical
1
2012
667
0.070
Why?
Genetic Variation
2
2012
985
0.070
Why?
HT29 Cells
2
2018
40
0.070
Why?
Cells, Cultured
6
2007
4190
0.070
Why?
Gene Expression
2
2003
1500
0.070
Why?
Europe
1
2007
413
0.060
Why?
ErbB Receptors
3
2016
613
0.060
Why?
Flow Cytometry
1
2010
1177
0.060
Why?
Clinical Trials as Topic
2
2015
1044
0.060
Why?
Thymine
1
2006
15
0.060
Why?
Genome, Human
1
2008
423
0.060
Why?
Cytosine
1
2006
49
0.060
Why?
Interleukin-1 Receptor-Associated Kinases
1
2006
30
0.060
Why?
Phentolamine
2
2002
15
0.060
Why?
Tumor Burden
2
2018
309
0.060
Why?
Inflammation Mediators
2
2006
513
0.060
Why?
Homozygote
1
2006
203
0.060
Why?
MAP Kinase Kinase 2
2
2002
28
0.060
Why?
Translocation, Genetic
1
2006
105
0.060
Why?
Propranolol
2
2002
50
0.060
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2007
974
0.060
Why?
MicroRNAs
1
2012
692
0.060
Why?
Survival Analysis
1
2008
1321
0.060
Why?
MAP Kinase Kinase 1
2
2002
75
0.060
Why?
Adolescent
3
2011
21382
0.060
Why?
Cell Nucleus
2
2006
617
0.060
Why?
Spheroids, Cellular
2
2016
76
0.060
Why?
Models, Biological
2
2018
1773
0.060
Why?
Introns
1
2006
256
0.060
Why?
Mitogen-Activated Protein Kinase 3
2
2002
152
0.060
Why?
Heat-Shock Proteins
1
2005
142
0.060
Why?
Exons
1
2006
351
0.060
Why?
Bone Marrow Cells
2
2003
316
0.060
Why?
Neoplasm Invasiveness
2
2016
507
0.050
Why?
Positron-Emission Tomography
2
2018
293
0.050
Why?
Cause of Death
1
2006
430
0.050
Why?
Shock, Septic
1
2006
219
0.050
Why?
Oxidants
1
2003
111
0.050
Why?
Organoids
1
2024
112
0.050
Why?
Deoxycytidine
1
2024
179
0.050
Why?
Paclitaxel
1
2024
227
0.050
Why?
Ribosomal Protein S6 Kinases
1
2002
21
0.050
Why?
Brimonidine Tartrate
1
2002
10
0.050
Why?
Models, Genetic
1
2005
599
0.050
Why?
Phenylephrine
1
2002
75
0.050
Why?
RNA Interference
2
2016
466
0.050
Why?
Quinoxalines
1
2002
66
0.050
Why?
Isoenzymes
1
2003
304
0.050
Why?
Hydrogen Peroxide
1
2003
327
0.050
Why?
Protein-Tyrosine Kinases
2
2002
434
0.050
Why?
Transcription, Genetic
2
2006
1455
0.050
Why?
Lung Neoplasms
1
2015
2489
0.050
Why?
Cyclic AMP-Dependent Protein Kinases
1
2002
135
0.050
Why?
Membrane Glycoproteins
1
2004
500
0.040
Why?
Free Radical Scavengers
1
2001
88
0.040
Why?
Neoplasm Proteins
3
2016
434
0.040
Why?
High Mobility Group Proteins
1
2000
44
0.040
Why?
Imidazoles
1
2001
238
0.040
Why?
MAP Kinase Signaling System
1
2002
320
0.040
Why?
Neutropenia
1
2000
146
0.040
Why?
Interleukin-1
2
2000
964
0.040
Why?
Protein Processing, Post-Translational
1
2002
465
0.040
Why?
Transcriptome
2
2016
969
0.040
Why?
Nuclear Proteins
2
2001
712
0.040
Why?
Adjuvants, Immunologic
1
2000
226
0.040
Why?
Trans-Activators
1
2001
398
0.040
Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
Why?
Colorado
1
2008
4518
0.040
Why?
4-Aminobenzoic Acid
1
2018
7
0.040
Why?
Up-Regulation
2
2016
843
0.030
Why?
Biomarkers
1
2008
4143
0.030
Why?
Protein Transport
1
2018
443
0.030
Why?
Pneumonia
1
2003
635
0.030
Why?
Retinal Dehydrogenase
1
2016
29
0.030
Why?
Inhibitory Concentration 50
1
2016
90
0.030
Why?
Hyaluronan Receptors
1
2016
102
0.030
Why?
Blotting, Western
2
2013
1225
0.030
Why?
Tissue Array Analysis
1
2016
57
0.030
Why?
Protein Interaction Maps
1
2016
48
0.030
Why?
Mice, Inbred C57BL
4
2015
5735
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
121
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
194
0.030
Why?
Chromatin Immunoprecipitation
1
2016
138
0.030
Why?
Papillomaviridae
1
2016
126
0.030
Why?
Prospective Studies
1
2007
7572
0.030
Why?
S-Phase Kinase-Associated Proteins
1
2015
20
0.030
Why?
Diphenylamine
1
2014
9
0.030
Why?
Iloprost
1
2015
45
0.030
Why?
Acid Phosphatase
1
2014
20
0.030
Why?
Cadherins
1
2016
205
0.030
Why?
Rhodamines
1
2014
20
0.030
Why?
G2 Phase
1
2014
38
0.030
Why?
Cell Division
1
2016
792
0.030
Why?
Gene Expression Regulation, Enzymologic
1
2016
283
0.030
Why?
Tumor Cells, Cultured
1
2016
953
0.030
Why?
Young Adult
1
2011
13129
0.030
Why?
Inflammation
1
2005
2834
0.030
Why?
Epithelial-Mesenchymal Transition
1
2016
209
0.030
Why?
Tretinoin
1
2015
123
0.030
Why?
Sequence Analysis, RNA
1
2016
452
0.030
Why?
Benzamides
1
2014
216
0.030
Why?
Antigens, CD
1
2016
521
0.030
Why?
Transfection
1
2016
941
0.030
Why?
Retrospective Studies
1
2011
15504
0.030
Why?
Receptor, Notch2
1
2013
15
0.030
Why?
Gonanes
1
2013
27
0.030
Why?
Alphapapillomavirus
1
2013
39
0.030
Why?
Receptors, CXCR
1
2012
3
0.020
Why?
Erlotinib Hydrochloride
1
2012
72
0.020
Why?
Cyclin D1
1
2012
68
0.020
Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2003
41
0.020
Why?
Disease-Free Survival
1
2014
685
0.020
Why?
Protein Binding
1
2018
2216
0.020
Why?
Active Transport, Cell Nucleus
2
2003
123
0.020
Why?
Tumor Suppressor Protein p53
1
2016
528
0.020
Why?
Computers
1
2012
70
0.020
Why?
Mice, Inbred C3H
2
2004
269
0.020
Why?
Maximum Tolerated Dose
1
2012
199
0.020
Why?
Niacinamide
1
2012
79
0.020
Why?
Phenylurea Compounds
1
2012
96
0.020
Why?
Tissue Distribution
1
2012
330
0.020
Why?
Injections, Intraperitoneal
2
2001
114
0.020
Why?
Mice, Knockout
3
2003
3003
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2012
139
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
2
2003
233
0.020
Why?
Calcium Signaling
1
2013
249
0.020
Why?
Xanthine Oxidase
2
2001
81
0.020
Why?
Acute Disease
2
2004
1004
0.020
Why?
United States
1
2007
14691
0.020
Why?
Cluster Analysis
1
2011
497
0.020
Why?
Ligands
1
2011
661
0.020
Why?
Vascular Endothelial Growth Factor A
1
2012
543
0.020
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2011
340
0.020
Why?
Survival Rate
1
2014
1962
0.020
Why?
Models, Molecular
1
2014
1570
0.020
Why?
Computational Biology
1
2013
643
0.020
Why?
Tumor Microenvironment
1
2012
672
0.020
Why?
Dose-Response Relationship, Drug
1
2012
2052
0.020
Why?
Cell Movement
1
2011
965
0.020
Why?
Adiposity
1
2012
518
0.020
Why?
Mice, Transgenic
2
2003
2160
0.020
Why?
Calcium
1
2013
1197
0.020
Why?
Oxidative Stress
2
2003
1314
0.020
Why?
Magnetic Resonance Imaging
1
2018
3555
0.020
Why?
Neutrophil Infiltration
1
2004
107
0.010
Why?
Permeability
1
2004
161
0.010
Why?
Transcription Factor AP-1
1
2003
92
0.010
Why?
Phosphotransferases
1
2003
24
0.010
Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2003
4
0.010
Why?
bcl-Associated Death Protein
1
2003
9
0.010
Why?
Aconitate Hydratase
1
2003
17
0.010
Why?
Toll-Like Receptors
1
2004
185
0.010
Why?
JNK Mitogen-Activated Protein Kinases
1
2003
162
0.010
Why?
Algorithms
1
2010
1689
0.010
Why?
Lipid Peroxidation
1
2003
153
0.010
Why?
Reproducibility of Results
1
2010
3264
0.010
Why?
Mice, Mutant Strains
1
2003
297
0.010
Why?
Extracellular Space
1
2003
119
0.010
Why?
Metalloporphyrins
1
2003
103
0.010
Why?
Replication Protein C
1
2001
4
0.010
Why?
Tumor Necrosis Factor alpha-Induced Protein 3
1
2001
11
0.010
Why?
bcl-X Protein
1
2001
43
0.010
Why?
Toll-Like Receptor 4
1
2004
273
0.010
Why?
Biological Transport
1
2003
416
0.010
Why?
Cysteine Endopeptidases
1
2001
72
0.010
Why?
Protein Kinases
1
2003
319
0.010
Why?
CREB-Binding Protein
1
2001
31
0.010
Why?
Transcription Factor RelA
1
2001
87
0.010
Why?
Tungsten
1
2001
30
0.010
Why?
Animal Feed
1
2001
53
0.010
Why?
Immune Sera
1
2000
88
0.010
Why?
Proto-Oncogene Proteins c-fos
1
2001
185
0.010
Why?
Mitogen-Activated Protein Kinase 1
1
2001
185
0.010
Why?
Organ Specificity
1
2000
304
0.010
Why?
Endotoxins
1
2000
220
0.010
Why?
Protein Biosynthesis
1
2001
430
0.010
Why?
Antioxidants
1
2003
584
0.010
Why?
Carrier Proteins
1
2003
769
0.010
Why?
Intubation, Intratracheal
1
2000
257
0.010
Why?
Treatment Outcome
1
2010
10744
0.010
Why?
Peptides
1
2001
979
0.010
Why?
Proteins
1
2001
1008
0.010
Why?
Arcaroli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)